Tampere – Finland’s Most Desirable City to Live in – Attracts Tech Talent From Europe
10.8.2023 21:46:00 EEST | Business Wire | Press release
Nestled in the world's happiest country, Tampere, a forward-thinking city, look towards Europe for skilled tech professionals and startup entrepreneurs. Tampere’s International House is hosting an online hackathon-style recruitment event, titled Game On!, on 14–15 September. As part of the hackathon, Tampere is inviting 12 applicants to experience the true Tampere lifestyle.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230810179331/en/
Tampere has a strong tech community and active ecosystems for example in machine learning, imaging, mobile and manufacturing technologies. (Photo: Business Wire)
Tampere is a city known for its courage to grow and go forward. Located in the heart of Finland, Tampere is home to blooming tech companies such as Valmet, Treon, and Colossal Order. Unlike the tech industry in many crowded cities, these tech companies can offer their employees an escape from the chaos and a lifestyle with affordable, easy-access housing and a high standard of living.
Tampere has a strong tech community and active ecosystems for example in machine learning, imaging, mobile and manufacturing technologies. The growing city and its tech industry need bright new tech minds. In the Experience Tampere campaign, European professionals are especially targeted.
Twelve of the tech professionals and startup founders who register for the event by 16 August also have a chance to win a five-day immersive experience in Tampere. There will be a versatile programme for both talents and startup owners coming to experience the hidden gem of Finland between the 12th and 16th of September.
"It will be a unique experience and an opportunity for the winners to meet the companies, get to know the city, its tech scene, and the lifestyle. Tampere will show that high tech can be combined with a vibrant community and chill sauna evenings by beautiful lakeside scenery," says Sini Vilppula, Vice President, Human Resources, at Automation System Business Line in Valmet.
For startup founders, the city organizes a programme where they get to explore the Startup Tampere ecosystem, visit co-working spaces, innovation centers, and accelerators, and feel the energy of the Platform 6 Startup House. Furthermore, connect with local startups, network with founders, gain insights from industry experts, and create new possibilities for their startups.
All participants get to experience Finnish culture with their families and discover the unique charm of Tampere, enjoy cultural activities, indulge in traditional Finnish cuisine, and build connections beyond business.
Further information:
Experience Tampere - International House Tampere
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230810179331/en/
Contact information
Marketing Specialist
Tiia Heikkilä
tiia.heikkila@tampere.fi
+358 41 730 2921
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cosylab Launches PlanOne™ Treatment Planning System for Particle Therapy8.6.2026 09:00:00 EEST | Press release
Cosylab today announced the commercial launch of PlanOne™, a treatment planning system for particle therapy, bringing physics-accurate, radiobiologically informed planning and a unified clinical workflow into a single environment. PlanOne™ is FDA 510(k) cleared. "PlanOne™ began with listening. Over the years, our work on control systems in radiation oncology has put us in direct, ongoing contact with medical physicists and clinical teams at some of the leading facilities in the world," said Mark Pleško, CEO of Cosylab. "Our partners have been clear on what matters most for particle therapy: physics accuracy they can defend, clinical confidence at the point of plan approval, and a platform built to grow with AI and adaptive workflows. We designed PlanOne™ around those three priorities, and we'll keep developing it together with the clinical community that helped shape it." Physics-accurate, radiobiologically informed planning PlanOne™ is built on a GPU-accelerated Monte Carlo dose engin
BitGo MENA Launches Regulated Electronic Trading, Delivering Full Suite Trading Services to the Region8.6.2026 07:00:00 EEST | Press release
BitGo MENA FZE (“BitGo MENA”), a subsidiary of BitGo Holdings, Inc. (NYSE: BTGO) (“BitGo”), the digital asset infrastructure company, today announced the launch of electronic trading in the Middle East and North African (MENA). With this launch, clients can now access a comprehensive trading solution combining BitGo MENA’s established over-the-counter (OTC) trading offering with institutional-grade electronic execution, all operating under BitGo MENA’s Broker-Dealer license from Dubai’s Virtual Assets Regulatory Authority (VARA). The launch further expands BitGo MENA’s regulated product suite under VARA’s oversight, marking another step in the region’s continued buildout of institutional digital asset infrastructure amid growing demand for integrated execution and custody solutions. “The Middle East and North Africa has quickly become one of the most exciting regions in the world for digital assets, with regulators, institutions, and innovators moving with real purpose,” said Mike Bels
Vertex Presents New Data on ALYFTREK ® at European Cystic Fibrosis Conference5.6.2026 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data demonstrating the potentially transformative impact of treating cystic fibrosis (CF) with ALYFTREK ® (vanzacaftor/tezacaftor/deutivacaftor) in children ages 2 to 5, as well as data from 96-week interim analyses of two open-label extension studies of ALYFTREK in children 6 to 11 years and people 12 years and older demonstrating the long-term safety and efficacy profile of the medicine. The data, presented at the European Cystic Fibrosis Conference, show children ages 2 to 5 with vanzacaftor/tezacaftor/deutivacaftor-responsive genotypes including those who are homozygous for the F508del mutation (F/F) and those who have F508del/minimal function mutations (F/MF)on ALYFTREK had further improvement in CFTR function from a TRIKAFTA ® baseline as measured by sweat chloride (SwCl), with 65% having achieved SwCl <30 mmol/L after treatment with ALYFTREK. Vertex also presented Phase 3 data of children ages 1 to <2 with TRIKAF
Owkin to Build AI Agents as Part of a Multi-Year K Pro Collaboration with Sanofi5.6.2026 14:00:00 EEST | Press release
Owkin, the agentic AI company pioneering Biological Artificial Superintelligence to transform drug discovery and development, today announced a multi-year collaboration with Sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260605704506/en/ K Pro, Owkin's AI scientist for biology, powered by multimodal patient data for smarter biopharma decision making. Owkin and Sanofi have collaborated since 2021 through a €90 million strategic partnership focused on target identification in oncology and patient subgrouping. The collaboration was later expanded to include drug positioning for Sanofi’s immunology pipeline. This new collaboration represents the next evolution in the partnership. During the five-year collaboration, Owkin will lead the end-to-end development of novel AI-driven biopharma agents purpose-built
DFNS Rebrands as the Core Banking Platform for Digital Assets5.6.2026 13:41:00 EEST | Press release
DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital assets. The company is introducing a new logo, website, and market position as fintechs and institutions move their products and operations onchain. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260603859127/en/ Banks, fintechs, asset managers, trading firms, payment providers, market infrastructures, and clearing houses have stopped asking how to "add crypto." They're asking how to run financial products, controls, workflows, and client services on blockchain rails, with the reliability expected of core infrastructure. Some are going further still, exploring whether the blockchain can serve as the ledger itself, where an account is an onchain object rather than a row in a database. Where IBANs, virtual accounts, and blockchain wallets converge into one governed financial account. “DFNS was built
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom